BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37958811)

  • 21. MC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair.
    Pellegrini C; Fargnoli MC; Suppa M; Peris K
    BMC Med Genet; 2012 Sep; 13():81. PubMed ID: 22978401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters.
    Karagianni F; Njauw CN; Kypreou KP; Stergiopoulou A; Plaka M; Polydorou D; Chasapi V; Pappas L; Stratigos IA; Champsas G; Panagiotou P; Gogas H; Evangelou E; Tsao H; Stratigos AJ; Stefanaki I
    Acta Derm Venereol; 2018 Oct; 98(9):862-866. PubMed ID: 29774366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of melanoma susceptibility genes in high-risk patients from Central Italy.
    Pellegrini C; Maturo MG; Martorelli C; Suppa M; Antonini A; Kostaki D; Verna L; Landi MT; Peris K; Fargnoli MC
    Melanoma Res; 2017 Jun; 27(3):258-267. PubMed ID: 28146043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Familial Melanoma in Valencia, Spain, Based on the Presence of CDKN2A Mutations and MC1R Variants.
    Huerta C; Garcia-Casado Z; Bañuls J; Moragon M; Oliver V; Unamuno B; Requena C; Kumar R; Nagore E
    Acta Derm Venereol; 2018 Apr; 98(5):512-516. PubMed ID: 29405243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
    Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
    Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
    de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
    Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.
    Sargen MR; Calista D; Elder DE; Massi D; Chu EY; Potrony M; Pfeiffer RM; Carrera C; Aguilera P; Alos L; Puig S; Elenitsas R; Yang XR; Tucker MA; Landi MT; Goldstein AM
    J Am Acad Dermatol; 2020 Sep; 83(3):860-869. PubMed ID: 32283231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.
    Puig S; Potrony M; Cuellar F; Puig-Butille JA; Carrera C; Aguilera P; Nagore E; Garcia-Casado Z; Requena C; Kumar R; Landman G; Costa Soares de Sá B; Gargantini Rezze G; Facure L; de Avila AL; Achatz MI; Carraro DM; Duprat Neto JP; Grazziotin TC; Bonamigo RR; Rey MC; Balestrini C; Morales E; Molgo M; Bakos RM; Ashton-Prolla P; Giugliani R; Larre Borges A; Barquet V; Pérez J; Martínez M; Cabo H; Cohen Sabban E; Latorre C; Carlos-Ortega B; Salas-Alanis JC; Gonzalez R; Olazaran Z; Malvehy J; Badenas C
    Genet Med; 2016 Jul; 18(7):727-36. PubMed ID: 26681309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variations of patients with familial or multiple melanoma in Southern Brazil.
    Grazziotin TC; Rey MC; Bica CG; Pinto LA; Bonamigo RR; Puig-Butille JA; Cuellar F; Puig S
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e179-85. PubMed ID: 22621339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Pissa M; Helkkula T; Appelqvist F; Silander G; Borg Å; Pettersson J; Lapins J; Nielsen K; Höiom V; Helgadottir H
    Acta Oncol; 2021 Jul; 60(7):888-896. PubMed ID: 33945383
    [No Abstract]   [Full Text] [Related]  

  • 33. Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD,
    Pastorino L; Andreotti V; Dalmasso B; Vanni I; Ciccarese G; Mandalà M; Spadola G; Pizzichetta MA; Ponti G; Tibiletti MG; Sala E; Genuardi M; Chiurazzi P; Maccanti G; Manoukian S; Sestini S; Danesi R; Zampiga V; La Starza R; Stanganelli I; Ballestrero A; Mastracci L; Grillo F; Sciallero S; Cecchi F; Tanda ET; Spagnolo F; Queirolo P; Italian Melanoma Intergroup (IMI) ; Goldstein AM; Bruno W; Ghiorzo P
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
    Chaudru V; Laud K; Avril MF; Minière A; Chompret A; Bressac-de Paillerets B; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2384-90. PubMed ID: 16214921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
    Cuéllar F; Puig S; Kolm I; Puig-Butille J; Zaballos P; Martí-Laborda R; Badenas C; Malvehy J
    Br J Dermatol; 2009 Jan; 160(1):48-53. PubMed ID: 18795926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma genetics.
    Read J; Wadt KA; Hayward NK
    J Med Genet; 2016 Jan; 53(1):1-14. PubMed ID: 26337759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High incidence of primary melanomas in an MC1R RHC homozygote/CDKN2A mutant genotype patient.
    Sinnya S; Jagirdar K; De'Ambrosis B; McMeniman E; Sturm RA; Soyer HP
    Arch Dermatol Res; 2015 Oct; 307(8):741-5. PubMed ID: 26103950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High- and low-penetrance cutaneous melanoma susceptibility genes.
    Fargnoli MC; Argenziano G; Zalaudek I; Peris K
    Expert Rev Anticancer Ther; 2006 May; 6(5):657-70. PubMed ID: 16759158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplex melanoma families are enriched for polygenic risk.
    Law MH; Aoude LG; Duffy DL; Long GV; Johansson PA; Pritchard AL; Khosrotehrani K; Mann GJ; Montgomery GW; Iles MM; Cust AE; Palmer JM; ; Shannon KF; Spillane AJ; Stretch JR; Thompson JF; Saw RPM; Scolyer RA; Martin NG; Hayward NK; MacGregor S
    Hum Mol Genet; 2020 Oct; 29(17):2976-2985. PubMed ID: 32716505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma.
    Koulermou G; Shammas C; Vassiliou A; Kyriakides TC; Costi C; Neocleous V; Phylactou LA; Pantelidou M
    J Genet; 2017 Mar; 96(1):155-160. PubMed ID: 28360400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.